Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer02:18

Cancer

53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adaptive therapy and its challenges.

Evolution, medicine, and public health·2026
Same author

Age identifies cancer drivers hidden within the genome.

Nature genetics·2026
Same author

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

Nature communications·2026
Same author

Stochastic Evolutionary Control in Heterogeneous Populations.

bioRxiv : the preprint server for biology·2026
Same author

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy.

Clinical genitourinary cancer·2025
Same author

Evolution under vancomycin selection drives divergent collateral sensitivity patterns in <i>Staphylococcus aureus</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

Another 10 years of PLOS Computational Biology: A data-driven reflection on trends in genomics research.

PLoS computational biology·2026
Same journal

Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data.

PLoS computational biology·2026
Same journal

DeepMethylation: A deep learning framework for tissue-specific DNA methylation prediction and functional variant annotation.

PLoS computational biology·2026
Same journal

Redefining and estimating the early-phase reproduction ratio for epidemic outbreaks in spatially structured populations.

PLoS computational biology·2026
Same journal

Optimized phenotype definitions boost GWAS power.

PLoS computational biology·2026
Same journal

Detection, communication, and individual identification with deep audio embeddings: A case study with North Atlantic right whales.

PLoS computational biology·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K

个性化化疗药物选择使用新型的转录化学化学图.

Kristi Lin-Rahardja1,2, Jessica Scarborough3, Jacob G Scott1,2,4

  • 1Systems Biology and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.

PLoS computational biology
|September 10, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了化学图谱,一种新的框架,使用基因签名来预测患者对各种化疗药物的反应. 化学图谱框架优化了针对个体瘤的癌症治疗选择,改善了精准医学结果.

更多相关视频

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

910
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K

相关实验视频

Last Updated: Jan 18, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

910
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.8K

科学领域:

  • 计算生物学是一种计算生物学.
  • 基因组学就是基因组学.
  • 精准医学是一门精准的医学.

背景情况:

  • 基因签名可以预测化疗反应,帮助精准医学.
  • 目前的方法通常预测对单一药物的反应,而不是组合.
  • 优化化疗方案需要预测对多种药物的敏感性.

研究的目的:

  • 开发一种统一的框架,即化疗图,用于使用预测基因签名对药物敏感性进行排名.
  • 为了能够有效地选多种疗法,以进行个性化癌症治疗.
  • 为了满足对未经治疗的癌症和耐药癌症的最佳化疗的需求.

主要方法:

  • 利用一种先前确立的方法来提取预测基因签名.
  • 将这些签名集成到化疗图框架中,以对个别瘤的药物敏感性进行排名.
  • 化学图谱预测的药物反应排名与各种癌症类型细胞系中观察到的反应进行了比较.

主要成果:

  • 化学图谱预测的准确性高于随机基因特征和差异性表达特征.
  • 该框架的准确性与另一种成熟的药物反应预测方法相美.
  • 化学图谱框架准确地在个体基础上对药物敏感性进行排名,并有效地扩展到更多的药物.

结论:

  • 化疗图框架有效地利用转录组签名来预测和排名化疗反应.
  • 这种方法通过优化个人患者的药物选择来增强精准医学的潜力.
  • 化疗图为个性化化疗方案设计提供了可扩展和准确的方法.